{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:48:49Z","timestamp":1790999329780,"version":"4.1.0"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/IG\/9\/2024-01026"],"award-info":[{"award-number":["EMDR\/IG\/9\/2024-01026"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.arr.2025.102961","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:08:09Z","timestamp":1764086889000},"page":"102961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Understanding glial cells: Implications for multiple sclerosis pathogenesis and therapeutics"],"prefix":"10.1016","volume":"114","author":[{"given":"Yadav Shubham","family":"Lalmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18052-8","article-title":"Natural variants of human SARM1 cause both intrinsic and dominant loss-of-function influencing axon survival","volume":"12","author":"Ademi","year":"2022","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.arr.2025.102961_bib2","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1177\/1352458515613641","article-title":"Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing\u2013remitting multiple sclerosis","volume":"22","author":"Ahlbrecht","year":"2016","journal-title":"Mult. Scler. J."},{"issue":"2","key":"10.1016\/j.arr.2025.102961_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.arr.2025.102961_bib4","article-title":"Multiple sclerosis presenting with progressive visual impairment independent of relapse activity: a case report","volume":"3","author":"Akaike","year":"2023","journal-title":"Neuroimmunol. Rep."},{"issue":"2","key":"10.1016\/j.arr.2025.102961_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.17712\/nsj.2023.2.20220102","article-title":"Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis","volume":"28","author":"Aldarwish","year":"2023","journal-title":"Neurosciences"},{"key":"10.1016\/j.arr.2025.102961_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114252","article-title":"Traumatic axonopathy in spinal tracts after impact acceleration head injury: ultrastructural observations and evidence of SARM1-dependent axonal degeneration","volume":"359","author":"Alexandris","year":"2023","journal-title":"Exp. Neurol."},{"issue":"16","key":"10.1016\/j.arr.2025.102961_bib7","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.3390\/ijms20163922","article-title":"Impact of Astrocyte Depletion upon Inflammation and Demyelination in a Murine Animal Model of Multiple Sclerosis","volume":"20","author":"Allnoch","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.arr.2025.102961_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s42000-020-00197-8","article-title":"Psycho-neuro-endocrino-immunologic issues in multiple sclerosis: a critical review of clinical and therapeutic implications","volume":"19","author":"Anagnostouli","year":"2020","journal-title":"Hormones"},{"issue":"5","key":"10.1016\/j.arr.2025.102961_bib9","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1111\/ejn.14969","article-title":"The effects of microglia- and astrocyte-derived factors on neurogenesis in health and disease","volume":"54","author":"Araki","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2025.102961_bib10","series-title":"In Meyler\u2019s Side Effects of Drugs","first-page":"498","article-title":"Leflunomide and teriflunomide","author":"Aronson","year":"2016"},{"key":"10.1016\/j.arr.2025.102961_bib11","doi-asserted-by":"crossref","unstructured":"Aydin, A.G., Lemenze, A., & Bieszczad, K.M. (2024). Functional diversities within neurons and astrocytes in the adult rat auditory cortex revealed by single-nucleus RNA sequencing (p. 2024.04.16.589831). bioRxiv. https:\/\/doi.org\/10.1101\/2024.04.16.589831.","DOI":"10.1101\/2024.04.16.589831"},{"issue":"2","key":"10.1016\/j.arr.2025.102961_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/biom12020222","article-title":"Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis","volume":"12","author":"Azzolini","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2025.102961_bib13","unstructured":"Babaesfahani, A., & Bajaj, T. (2024). Glatiramer. In StatPearls. StatPearls Publishing. \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541007\/\u3009."},{"key":"10.1016\/j.arr.2025.102961_bib14","unstructured":"Babaesfahani, A., Khanna, N.R., & Kuns, B. (2024). Natalizumab. In StatPearls. StatPearls Publishing. \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534201\/\u3009."},{"issue":"11","key":"10.1016\/j.arr.2025.102961_bib15","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1002\/eji.200636483","article-title":"TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells","volume":"37","author":"Barr","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib16","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41467-019-14198-8","article-title":"Identification of region-specific astrocyte subtypes at single cell resolution","volume":"11","author":"Batiuk","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.arr.2025.102961_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/neurolint13020022","article-title":"Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS)","volume":"13","author":"Berger","year":"2021","journal-title":"Neurol. Int."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s42466-019-0045-x","article-title":"Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response","volume":"1","author":"Bierhansl","year":"2019","journal-title":"Neurol. Res. Pract."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41583-022-00641-1","article-title":"Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders","volume":"24","author":"Brandebura","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"issue":"10076","key":"10.1016\/j.arr.2025.102961_bib20","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: progress and challenges","volume":"389","author":"Brownlee","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.arr.2025.102961_bib21","first-page":"2065","article-title":"Clinically isolated syndromes and the relationship to multiple sclerosis","volume":"21","author":"Brownlee","year":"2014","journal-title":"Journal Clinical Neuroscience Official Journal Neurosurgical Society Australasia"},{"issue":"8","key":"10.1016\/j.arr.2025.102961_bib22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tins.2023.05.007","article-title":"Emerging roles of oligodendrocyte precursor cells in neural circuit development and remodeling","volume":"46","author":"Buchanan","year":"2023","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.arr.2025.102961_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1474-4422(14)70068-7","article-title":"Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study","volume":"13","author":"Calabresi","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.474","article-title":"Transition to secondary progressive multiple sclerosis: the consequences for patients and healthcare systems, a healthcare professional survey","volume":"5","author":"Caseby","year":"2022","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.arr.2025.102961_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jnc.13062","article-title":"Microglia and neuroprotection","volume":"136","author":"Chen","year":"2016","journal-title":"Journal of neurochemistry"},{"issue":"12","key":"10.1016\/j.arr.2025.102961_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189380","article-title":"Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination","volume":"12","author":"Chen","year":"2017","journal-title":"PLOS ONE"},{"issue":"S1","key":"10.1016\/j.arr.2025.102961_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/cen3.12438","article-title":"Dysregulated T cells in multiple sclerosis","volume":"9","author":"Chihara","year":"2018","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.arr.2025.102961_bib28","doi-asserted-by":"crossref","DOI":"10.1101\/2025.03.17.643488","article-title":"Varicose-projection astrocytes: a reactive phenotype associated with neuropathology","author":"Ciani","year":"2025","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.arr.2025.102961_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-022-00927-z","article-title":"The two sides of siponimod: evidence for brain and immune mechanisms in multiple sclerosis","volume":"36","author":"Cohan","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arr.2025.102961_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2023.102307","article-title":"Astrocyte signaling and interactions in Multiple Sclerosis","volume":"86","author":"Col\u00f3n Ortiz","year":"2024","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40893-016-0010-2","article-title":"The heritage of glatiramer acetate and its use in multiple sclerosis","volume":"1","author":"Comi","year":"2016","journal-title":"Mult. Scler. Demyelinating Disord."},{"issue":"8","key":"10.1016\/j.arr.2025.102961_bib32","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s10072-019-03889-1","article-title":"A complex relation between depression and multiple sclerosis: a descriptive review","volume":"40","author":"Corallo","year":"2019","journal-title":"Neurol. Sci."},{"issue":"9","key":"10.1016\/j.arr.2025.102961_bib33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-022-00697-8","article-title":"The role of the gut microbiota in multiple sclerosis","volume":"18","author":"Correale","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102961_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/17590914221118502","article-title":"Multiple sclerosis and aging: the dynamics of demyelination and remyelination","volume":"14","author":"Correale","year":"2022","journal-title":"ASN Neuro"},{"key":"10.1016\/j.arr.2025.102961_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1135540","article-title":"Central nervous system demyelinating diseases: glial cells at the hub of pathology","volume":"14","author":"Coutinho Costa","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2025.102961_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fncel.2018.00024","article-title":"Reduced synapse and axon numbers in the prefrontal cortex of rats subjected to a chronic stress model for depression","volume":"12","author":"Csabai","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"11","key":"10.1016\/j.arr.2025.102961_bib37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.tins.2021.07.002","article-title":"Macrophages on the margin: choroid plexus immune responses","volume":"44","author":"Cui","year":"2021","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","article-title":"Promoting remyelination in multiple sclerosis","volume":"268","author":"Cunniffe","year":"2021","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib39","first-page":"267","article-title":"Astrocyte phenotypes: Emphasis on potential markers in neuroinflammation","volume":"36","author":"Danijela","year":"2021","journal-title":"Histol. Histopathol."},{"issue":"6","key":"10.1016\/j.arr.2025.102961_bib40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7224\/1537-2073.2020-023","article-title":"Update on recent developments in communication and swallowing in multiple sclerosis","volume":"22","author":"De Biagi","year":"2020","journal-title":"Int. J. MS Care"},{"issue":"6","key":"10.1016\/j.arr.2025.102961_bib41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41582-020-0355-1","article-title":"Treatment and management of cognitive dysfunction in patients with multiple sclerosis","volume":"16","author":"DeLuca","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.arr.2025.102961_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cimb45050272","article-title":"CNS border-associated macrophages: ontogeny and potential implication in disease","volume":"45","author":"Dermitzakis","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"5","key":"10.1016\/j.arr.2025.102961_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cimb45050272","article-title":"CNS border-associated macrophages: ontogeny and potential implication in disease","volume":"45","author":"Dermitzakis","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"10","key":"10.1016\/j.arr.2025.102961_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41583-018-0053-9","article-title":"Multiple sclerosis and cognition: synaptic failure and network dysfunction","volume":"19","author":"Di Filippo","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.arr.2025.102961_bib45","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.4103\/1673-5374.306064","article-title":"Astrocytes: a double-edged sword in neurodegenerative diseases","volume":"16","author":"Ding","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2025.102961_bib46","article-title":"Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair","volume":"4","author":"Domingues","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.arr.2025.102961_bib47","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/glia.23058","article-title":"Activation of the astrocytic Nrf2\/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model: Astrocytic Nrf2 Hyperactivation Prevents the Formation of Demyelinating Lesions","volume":"64","author":"Draheim","year":"2016","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.arr.2025.102961_bib48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/hcaa348","article-title":"Beta interferons as immunotherapy in multiple sclerosis: A new outlook on a classic drug during the COVID-19 pandemic","volume":"114","author":"Dumitrescu","year":"2021","journal-title":"QJM Int. J. Med."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12974-022-02476-0","article-title":"Network alterations underlying anxiety symptoms in early multiple sclerosis","volume":"19","author":"Ellwardt","year":"2022","journal-title":"J. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.arr.2025.102961_bib50","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/biomedicines10061236","article-title":"Co-Ultramicronized Palmitoylethanolamide\/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-\u03b1 in an In Vitro Model of Alzheimer\u2019s Disease","volume":"10","author":"Facchinetti","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/1673-5374.340405","article-title":"Astrocyte evolution and human specificity","volume":"18","author":"Falcone","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/glia.24093","article-title":"Redefining varicose projection astrocytes in primates","volume":"70","author":"Falcone","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.arr.2025.102961_bib53","doi-asserted-by":"crossref","DOI":"10.1101\/2022.12.08.519209","article-title":"SARM1 detection in oligodendrocytes but not Schwann cells though sarm1\/Sarm1 deletion does not perturb CNS nor PNS myelination in zebrafish and mice","author":"Fazal","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2025.102961_bib54","doi-asserted-by":"crossref","DOI":"10.1101\/2022.12.08.519209","article-title":"SARM1 detection in oligodendrocytes but not Schwann cells though sarm1\/Sarm1 deletion does not perturb CNS nor PNS myelination in zebrafish and mice","author":"Fazal","year":"2022","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib55","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ana.25808","article-title":"Identifying Progression in Multiple Sclerosis: New Perspectives","volume":"88","author":"Filippi","year":"2020","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clim.2010.11.011","article-title":"DNA-based vaccines for multiple sclerosis: Current status and future directions","volume":"142","author":"Fissolo","year":"2012","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.arr.2025.102961_bib57","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40120-023-00565-7","article-title":"Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives","volume":"13","author":"Freedman","year":"2024","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.arr.2025.102961_bib58","series-title":"Gene Therapy for Autoimmune and Inflammatory Diseases","first-page":"65","article-title":"Gene therapy of multiple sclerosis","author":"Furlan","year":"2010"},{"issue":"7","key":"10.1016\/j.arr.2025.102961_bib59","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s10571-023-01397-7","article-title":"Single-Cell RNA-Sequencing in Astrocyte Development, Heterogeneity, and Disease","volume":"43","author":"Gao","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"7211","key":"10.1016\/j.arr.2025.102961_bib60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature07287","article-title":"An intrinsic mechanism of corticogenesis from embryonic stem cells","volume":"455","author":"Gaspard","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.arr.2025.102961_bib61","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/ijms20020448","article-title":"Facets of Theiler\u2019s Murine Encephalomyelitis Virus-Induced Diseases: An Update","volume":"20","author":"Gerhauser","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib62","first-page":"1","article-title":"Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell Journal (Yakhteh)"},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib63","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jnr.25151","article-title":"Emerging mitochondrial-mediated mechanisms involved in oligodendrocyte development","volume":"101","author":"Gil","year":"2023","journal-title":"J. Neurosci. Res."},{"issue":"9","key":"10.1016\/j.arr.2025.102961_bib64","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1007\/s00415-022-11166-z","article-title":"Siponimod vs placebo in active secondary progressive multiple sclerosis: A post hoc analysis from the phase 3 EXPAND study","volume":"269","author":"Gold","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2025.102961_bib65","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3389\/fimmu.2020.00374","article-title":"Microglia in Multiple Sclerosis: Friend or Foe?","volume":"11","author":"Guerrero","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.arr.2025.102961_bib66","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/aja.2011.110","article-title":"Multiple sclerosis and sexual dysfunction","volume":"14","author":"Guo","year":"2012","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.arr.2025.102961_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia Polarization From M1 to M2 in Neurodegenerative Diseases","volume":"14","author":"Guo","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102961_bib68","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211007687","article-title":"Inflammation in multiple sclerosis","volume":"14","author":"Haase","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/glia.23556","article-title":"The formation of a glial scar does not prohibit remyelination in an animal model of multiple sclerosis","volume":"67","author":"Haindl","year":"2019","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.arr.2025.102961_bib70","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7224\/1537-2073.2020-015","article-title":"Relationship Between Interpersonal Depressive Symptoms and Reduced Amygdala Volume in People with Multiple Sclerosis","volume":"23","author":"Haines","year":"2021","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.arr.2025.102961_bib71","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41869","article-title":"Circulating transforming growth factor-\u03b21 facilitates remyelination in the adult central nervous system","volume":"8","author":"Hamaguchi","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.arr.2025.102961_bib72","series-title":"The Choroid Plexus and Cerebrospinal Fluid","first-page":"29","article-title":"Chapter 3 - Choroid Plexus: Structure and Function","author":"Hofman","year":"2016"},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29206-y","article-title":"Natural Course of Clinically Isolated Syndrome: A Longitudinal Analysis Using a Markov Model","volume":"8","author":"Hou","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib74","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12264-022-00981-z","article-title":"Interactions Between Astrocytes and Oligodendroglia in Myelin Development and Related Brain Diseases","volume":"39","author":"Hu","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108588","article-title":"Small Molecule SARM1 Inhibitors Recapitulate the SARM1\u2212\/\u2212 Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate","volume":"34","author":"Hughes","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2025.102961_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.714169","article-title":"Premyelinating Oligodendrocytes: Mechanisms Underlying Cell Survival and Integration","volume":"9","author":"Hughes","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib77","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/glia.24300","article-title":"hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis","volume":"71","author":"Jahanbazi Jahan-Abad","year":"2023","journal-title":"Glia"},{"issue":"10422","key":"10.1016\/j.arr.2025.102961_bib78","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.arr.2025.102961_bib79","doi-asserted-by":"crossref","first-page":"a032003","DOI":"10.1101\/cshperspect.a032003","article-title":"Interferon \u03b2 for Multiple Sclerosis","volume":"8","author":"Jakimovski","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12974-022-02637-1","article-title":"Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases","volume":"19","author":"Javanmehr","year":"2022","journal-title":"J. Neuroinflamm."},{"issue":"9","key":"10.1016\/j.arr.2025.102961_bib81","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41419-022-05202-z","article-title":"Astrocytic SARM1 promotes neuroinflammation and axonal demyelination in experimental autoimmune encephalomyelitis through inhibiting GDNF signaling","volume":"13","author":"Jin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.arr.2025.102961_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102904","article-title":"Depression in multiple sclerosis: Is one approach for its management enough?","volume":"51","author":"Jones","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102961_bib83","doi-asserted-by":"crossref","DOI":"10.1101\/2022.12.07.22283104","article-title":"Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: a systematic review","author":"Kampaite","year":"2022","journal-title":"Radiol. Imaging"},{"issue":"22","key":"10.1016\/j.arr.2025.102961_bib84","doi-asserted-by":"crossref","first-page":"12033","DOI":"10.3390\/ijms252212033","article-title":"Altered Steroidome in Women with Multiple Sclerosis","volume":"25","author":"Kancheva","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40265-021-01650-7","article-title":"Ofatumumab: a review in relapsing forms of multiple sclerosis","volume":"82","author":"Kang","year":"2022","journal-title":"Drugs"},{"issue":"10127","key":"10.1016\/j.arr.2025.102961_bib86","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2025.102961_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577599","article-title":"Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients","volume":"356","author":"Kelly","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib88","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-neuro-070918-050443","article-title":"The emerging nature of astrocyte diversity","volume":"42","author":"Khakh","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.juro.2018.07.066","article-title":"Higher Neural Correlates in Patients with Multiple Sclerosis and Neurogenic Overactive Bladder Following Treatment with Intradetrusor Injection of OnabotulinumtoxinA","volume":"201","author":"Khavari","year":"2019","journal-title":"J. Urol."},{"issue":"9","key":"10.1016\/j.arr.2025.102961_bib90","doi-asserted-by":"crossref","first-page":"a028928","DOI":"10.1101\/cshperspect.a028928","article-title":"Clinical course of multiple sclerosis","volume":"8","author":"Klineova","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"6","key":"10.1016\/j.arr.2025.102961_bib91","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/glia.24145","article-title":"Phagocytic astrocytes: emerging from the shadows of microglia","volume":"70","author":"Konishi","year":"2022","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib92","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11055-016-0231-z","article-title":"Brain microglia and microglial markers","volume":"46","author":"Korzhevskii","year":"2016","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.arr.2025.102961_bib93","series-title":"Comprehensive Medicinal Chemistry III","first-page":"439","article-title":"Therapeutic approaches to MS and other neurodegenerative diseases","author":"Kotra","year":"2017"},{"issue":"11","key":"10.1016\/j.arr.2025.102961_bib94","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/cells8111424","article-title":"Oligodendrocytes in development, myelin generation and beyond","volume":"8","author":"Kuhn","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib95","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3390\/ijms24032336","article-title":"Dual role of B cells in multiple sclerosis","volume":"24","author":"Kumar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102961_bib96","doi-asserted-by":"crossref","first-page":"173877","DOI":"10.1016\/j.ejphar.2021.173877","article-title":"\u03b2-Lactam antibiotics to tame down molecular pathways of Alzheimer\u2019s disease","volume":"895","author":"Kumari","year":"2021","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.arr.2025.102961_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.824411","article-title":"Astrocytes and Inflammatory T Helper Cells: A Dangerous Liaison in Multiple Sclerosis","volume":"13","author":"Kunkl","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.arr.2025.102961_bib98","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.3390\/microorganisms11122840","article-title":"The Potential Role of Fecal Microbiota Transplant in the Reversal or Stabilization of Multiple Sclerosis Symptoms: A Literature Review on Efficacy and Safety","volume":"11","author":"Laeeq","year":"2023","journal-title":"Microorganisms"},{"issue":"18","key":"10.1016\/j.arr.2025.102961_bib99","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200151","article-title":"Racial and Ethnic Disparities in Multiple Sclerosis Prevalence","volume":"98","author":"Langer-Gould","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102961_bib100","series-title":"Neuroimmunology","first-page":"507","article-title":"Symptom Management in Multiple Sclerosis","author":"Langston","year":"2021"},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/neurolint12030016","article-title":"Ozanimod to treat relapsing forms of multiple sclerosis: a comprehensive review of disease, drug efficacy and side effects","volume":"12","author":"Lassiter","year":"2020","journal-title":"Neurol. Int."},{"key":"10.1016\/j.arr.2025.102961_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis","volume":"9","author":"Lassmann","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.arr.2025.102961_bib103","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40265-023-01854-z","article-title":"Ublituximab: first approval","volume":"83","author":"Lee","year":"2023","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib104","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/ijms23031337","article-title":"Genome Editing Using CRISPR-Cas9 and Autoimmune Diseases: A Comprehensive Review","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102961_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.701673","article-title":"Classification of Microglial Morphological Phenotypes Using Machine Learning","volume":"15","author":"Leyh","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"8","key":"10.1016\/j.arr.2025.102961_bib106","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152187","article-title":"The Eph receptor A4 plays a role in demyelination and depression-related behavior","volume":"132","author":"Li","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.arr.2025.102961_bib107","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3389\/fimmu.2020.01024","article-title":"Interaction of Microglia and Astrocytes in the Neurovascular Unit","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2025.102961_bib108","article-title":"Microglia: A Double-Edged Sword in Intracerebral Hemorrhage From Basic Mechanisms to Clinical Research","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib109","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12974-015-0271-2","article-title":"Mature oligodendrocytes actively increase in vivo cytoskeletal plasticity following CNS damage","volume":"12","author":"Locatelli","year":"2015","journal-title":"J. Neuroinflamm."},{"issue":"16","key":"10.1016\/j.arr.2025.102961_bib110","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.3390\/ijms241612912","article-title":"Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis","volume":"24","author":"L\u00f3pez-Muguruza","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102961_bib111","first-page":"89","article-title":"Demyelination in multiple sclerosis","volume":"122","author":"Lubetzki","year":"2014"},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib112","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3390\/ijms24031861","article-title":"Role of Microglial Cells in the Pathophysiology of MS: Synergistic or Antagonistic?","volume":"24","author":"Mado","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.arr.2025.102961_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.696","article-title":"The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis","volume":"7","author":"Madsen","year":"2017","journal-title":"Brain Behav."},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib114","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/WCO.0000000000000695","article-title":"The changing course of multiple sclerosis: Rising incidence, change in geographic distribution, disease course, and prognosis","volume":"32","author":"Magyari","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"10","key":"10.1016\/j.arr.2025.102961_bib115","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/brainsci10100722","article-title":"Tremor in Multiple Sclerosis\u2014An Overview and Future Perspectives","volume":"10","author":"Makhoul","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.arr.2025.102961_bib116","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.niox.2019.11.005","article-title":"Nitric oxide signaling inhibits microglia proliferation by activation of protein kinase-G","volume":"94","author":"Maksoud","year":"2020","journal-title":"Nitric Oxide"},{"issue":"7","key":"10.1016\/j.arr.2025.102961_bib117","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1474-4422(08)70138-8","article-title":"Autologous haematopoietic stem-cell transplantation in multiple sclerosis","volume":"7","author":"Mancardi","year":"2008","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.arr.2025.102961_bib118","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/eye.2016.258","article-title":"Fingolimod: Therapeutic mechanisms and ocular adverse effects","volume":"31","author":"Mandal","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.arr.2025.102961_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.854390","article-title":"Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure","volume":"13","author":"Manouchehri","year":"2022","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib120","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41398-023-02555-7","article-title":"Depressive symptoms, anxiety and cognitive impairment: Emerging evidence in multiple sclerosis","volume":"13","author":"Margoni","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"12","key":"10.1016\/j.arr.2025.102961_bib121","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/vaccines9121456","article-title":"Myelin Peptide\u2013Mannan Conjugate Multiple Sclerosis Vaccines: Conjugation Efficacy and Stability of Vaccine Ingredient","volume":"9","author":"Matsoukas","year":"2021","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.arr.2025.102961_bib122","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and Treatment of Multiple Sclerosis: A Review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"issue":"7942","key":"10.1016\/j.arr.2025.102961_bib123","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-022-05534-y","article-title":"Microglia regulate central nervous system myelin growth and integrity","volume":"613","author":"McNamara","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.102961_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.644126","article-title":"Ion Channels and Electrophysiological Properties of Astrocytes: Implications for Emergent Stimulation Technologies","volume":"15","author":"McNeill","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2025.102961_bib125","first-page":"119","article-title":"The stress-axis in multiple sclerosis: Clinical, cellular, and molecular aspects","volume":"181","author":"Melief","year":"2021"},{"issue":"5","key":"10.1016\/j.arr.2025.102961_bib126","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.it.2024.03.007","article-title":"Brain border-associated macrophages: Common denominators in infection, aging, and Alzheimer\u2019s disease?","volume":"45","author":"Mesquita","year":"2024","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.arr.2025.102961_bib127","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1474-4422(07)70243-0","article-title":"Primary-progressive multiple sclerosis","volume":"6","author":"Miller","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102961_bib128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fneur.2018.00005","article-title":"Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis","volume":"9","author":"Mills","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2025.102961_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1376931","article-title":"Editorial: Oligodendrocytes: from their development to function and dysfunction","volume":"18","author":"Miyata","year":"2024","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib130","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1038\/s41467-023-39046-8","article-title":"Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration","volume":"14","author":"Molina-Gonzalez","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib131","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s42003-022-04248-1","article-title":"Chronic oligodendrocyte injury in central nervous system pathologies","volume":"5","author":"Molina-Gonzalez","year":"2022","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib132","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3233\/ADR-210052","article-title":"Is There Any Evidence of Monocytes Involvement in Alzheimer\u2019s Disease? A Pilot Study on Human Postmortem Brain","volume":"5","author":"Monoranu","year":"2021","journal-title":"J. Alzheimer\u2019S. Dis. Rep."},{"issue":"5","key":"10.1016\/j.arr.2025.102961_bib133","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/ETLS20210164","article-title":"Remyelination: What are the prospects for regenerative therapies in multiple sclerosis?","volume":"5","author":"Moore","year":"2021","journal-title":"Emerg. Top. Life Sci."},{"key":"10.1016\/j.arr.2025.102961_bib134","article-title":"The mutational landscape of single neurons and oligodendrocytes reveals evidence of inflammation-associated","author":"Motyer","year":"2022","journal-title":"DNA Damage Mult. Scler."},{"key":"10.1016\/j.arr.2025.102961_bib135","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418773025","article-title":"Ocrelizumab: A new milestone in multiple sclerosis therapy","volume":"11","author":"Mulero","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"8","key":"10.1016\/j.arr.2025.102961_bib136","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jnnp-2016-315367","article-title":"Neuropsychiatric syndromes of multiple sclerosis","volume":"88","author":"Murphy","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.arr.2025.102961_bib137","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jnnp-2016-315367","article-title":"Neuropsychiatric syndromes of multiple sclerosis","volume":"88","author":"Murphy","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.arr.2025.102961_bib138","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4103\/1673-5374.355749","article-title":"Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury","volume":"18","author":"Myatich","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"9","key":"10.1016\/j.arr.2025.102961_bib139","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s10072-023-06794-w","article-title":"Safety and efficacy of cladribine in multiple sclerosis: A systematic review and meta-analysis","volume":"44","author":"Nabizadeh","year":"2023","journal-title":"Neurol. Sci."},{"issue":"7","key":"10.1016\/j.arr.2025.102961_bib140","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s42255-022-00610-z","article-title":"Glial cells as integrators of peripheral and central signals in the regulation of energy homeostasis","volume":"4","author":"Nampoothiri","year":"2022","journal-title":"Nat. Metab."},{"issue":"8","key":"10.1016\/j.arr.2025.102961_bib141","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1352458514558474","article-title":"Structural \u2018connectomic\u2019 alterations in the limbic system of multiple sclerosis patients with major depression","volume":"21","author":"Nigro","year":"2015","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.arr.2025.102961_bib142","article-title":"The Contribution of SARM1 to axonal degeneration in CNS inflammatory disorders","author":"Njoku","year":"2018","journal-title":"VCU Theses Diss."},{"issue":"12","key":"10.1016\/j.arr.2025.102961_bib143","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.autrev.2018.06.010","article-title":"What speech can tell us: A systematic review of dysarthria characteristics in Multiple Sclerosis","volume":"17","author":"Noffs","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.arr.2025.102961_bib144","article-title":"Azathioprine for people with multiple sclerosis","volume":"2021","author":"Nonino","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/glia.24621","article-title":"Are we there yet? Exploring astrocyte heterogeneity one cell at a time","volume":"73","author":"O\u2019Dea","year":"2025","journal-title":"Glia"},{"issue":"5\u20136","key":"10.1016\/j.arr.2025.102961_bib146","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/21678421.2024.2346825","article-title":"ALSUntangled #75: Portable neuromodulation stimulator therapy","volume":"25","author":"Officer","year":"2024","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"issue":"6","key":"10.1016\/j.arr.2025.102961_bib147","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","article-title":"Multiple sclerosis: Clinical aspects","volume":"31","author":"Oh","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.arr.2025.102961_bib148","first-page":"247","article-title":"Microglial NLRP3 inflammasome activation in multiple sclerosis","volume":"119","author":"Olcum","year":"2020"},{"issue":"11","key":"10.1016\/j.arr.2025.102961_bib149","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1177\/1352458516643600","article-title":"Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper","volume":"22","author":"Otero-Romero","year":"2016","journal-title":"Mult. Scler. J."},{"issue":"9","key":"10.1016\/j.arr.2025.102961_bib150","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1590\/0004-282x20180091","article-title":"Basal cortisol levels and the relationship with clinical symptoms in multiple sclerosis: A systematic review","volume":"76","author":"Pereira","year":"2018","journal-title":"Arq. De. NeuroPsiquiatr."},{"key":"10.1016\/j.arr.2025.102961_bib151","doi-asserted-by":"crossref","unstructured":"Pf\u00f6rtner, R. (2013). Astroglial and therapeutic factors affect demyelination in murine models with toxic demyelination [Georg-August-University G\u00f6ttingen]. https:\/\/doi.org\/10.53846\/goediss-3801.","DOI":"10.53846\/goediss-3801"},{"issue":"9","key":"10.1016\/j.arr.2025.102961_bib152","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrd.2017.115","article-title":"Remyelination therapies: A new direction and challenge in multiple sclerosis","volume":"16","author":"Plemel","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib153","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/11206430-000000000-00000","article-title":"Interferon-\u03b2-1b: A Review of its Use in Multiple Sclerosis","volume":"25","author":"Plosker","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arr.2025.102961_bib154","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fimmu.2018.00217","article-title":"The Role of Astrocytes in Multiple Sclerosis","volume":"9","author":"Ponath","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2025.102961_bib155","series-title":"In Encyclopedia of Cell Biology","first-page":"666","article-title":"Neuroinflammation in Multiple Sclerosis","author":"Prasad","year":"2023"},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib156","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41232-022-00193-y","article-title":"Central nervous system regeneration: The roles of glial cells in the potential molecular mechanism underlying remyelination","volume":"42","author":"Quan","year":"2022","journal-title":"Inflamm. Regen."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib157","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10286-015-0325-7","article-title":"Autonomic dysfunction, immune regulation, and multiple sclerosis","volume":"26","author":"Racosta","year":"2016","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.arr.2025.102961_bib158","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jconrel.2022.02.009","article-title":"Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis","volume":"343","author":"Rahiman","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2025.102961_bib159","series-title":"In Translational Neuroimmunology in Multiple Sclerosis","first-page":"15","article-title":"Immune Dysregulation in Multiple Sclerosis","author":"Regev","year":"2016"},{"key":"10.1016\/j.arr.2025.102961_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105493","article-title":"Mitoxantrone, pixantrone and mitoxantrone (2-hydroxyethyl)piperazine are toll-like receptor 4 antagonists, inhibit NF-\u03baB activation, and decrease TNF-alpha secretion in primary microglia","volume":"154","author":"Rinne","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.arr.2025.102961_bib161","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(18)30309-0","article-title":"The hippocampus in multiple sclerosis","volume":"17","author":"Rocca","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102961_bib162","unstructured":"Rocha Cabrero, F., & Morrison, E.H. (2024). Cladribine. In StatPearls. StatPearls Publishing. \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545307\/\u3009."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib163","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The Immune Response in Multiple Sclerosis","volume":"17","author":"Rodr\u00edguez Mur\u00faa","year":"2022","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib164","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1192\/bja.2017.19","article-title":"The neuropsychiatry of multiple sclerosis","volume":"24","author":"Ron","year":"2018","journal-title":"BJPsych Adv."},{"issue":"16","key":"10.1016\/j.arr.2025.102961_bib165","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005331","article-title":"Temporal trends in multiple sclerosis prevalence and incidence in a large population","volume":"90","author":"Rotstein","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102961_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103749","article-title":"Functions of astrocytes in multiple sclerosis: A review","volume":"60","author":"Salles","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102961_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103108","article-title":"The network collapse in multiple sclerosis: An overview of novel concepts to address disease dynamics","volume":"35","author":"Schoonheim","year":"2022","journal-title":"NeuroImage Clin."},{"issue":"16","key":"10.1016\/j.arr.2025.102961_bib168","doi-asserted-by":"crossref","first-page":"8751","DOI":"10.3390\/ijms25168751","article-title":"Primary Progressive Multiple Sclerosis\u2014A Key to Understanding and Managing Disease Progression","volume":"25","author":"Sempik","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.arr.2025.102961_bib169","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0972-2327.164827","article-title":"Symptomatic management in multiple sclerosis","volume":"18","author":"Shah","year":"2015","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein\u2013Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib171","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s42003-024-06540-8","article-title":"Astrocytes enhance plasticity response during reversal learning","volume":"7","author":"Squadrani","year":"2024","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib172","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12974-024-03059-x","article-title":"Border-associated macrophages in the central nervous system","volume":"21","author":"Sun","year":"2024","journal-title":"J. Neuroinflamm."},{"issue":"8","key":"10.1016\/j.arr.2025.102961_bib173","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s10571-021-01159-3","article-title":"Heterogeneity and Molecular Markers for CNS Glial Cells Revealed by Single-Cell Transcriptomics","volume":"42","author":"Sun","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.arr.2025.102961_bib174","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s10571-021-01159-3","article-title":"Heterogeneity and Molecular Markers for CNS Glial Cells Revealed by Single-Cell Transcriptomics","volume":"42","author":"Sun","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102961_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.589146","article-title":"Ozanimod for Treatment of Relapsing-Remitting Multiple Sclerosis in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"11","author":"Sun","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.arr.2025.102961_bib176","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3390\/cells12151942","article-title":"Microglia\u2013Astrocyte Interaction in Neural Development and Neural Pathogenesis","volume":"12","author":"Sun","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib177","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1352458517737390","article-title":"Investigation of probiotics in multiple sclerosis","volume":"24","author":"Tankou","year":"2018","journal-title":"Mult. Scler. J."},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib178","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41582-020-00439-8","article-title":"Mind the gap: From neurons to networks to outcomes in multiple sclerosis","volume":"17","author":"the MAGNIMS Study Group","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"17","key":"10.1016\/j.arr.2025.102961_bib179","doi-asserted-by":"crossref","first-page":"9588","DOI":"10.3390\/ijms25179588","article-title":"Glial cells as key regulators in neuroinflammatory mechanisms associated with multiple sclerosis","volume":"25","author":"Theophanous","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib180","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00011-022-01677-w","article-title":"Tissue-resident immune cells in the pathogenesis of multiple sclerosis","volume":"72","author":"Tian","year":"2023","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib181","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-11-12","article-title":"Morphometric characterization of microglial phenotypes in human cerebral cortex","volume":"11","author":"Torres-Platas","year":"2014","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib182","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s12035-018-1057-1","article-title":"Inactivation of Basolateral Amygdala Prevents Stress-Induced Astroglial Loss in the Prefrontal Cortex","volume":"56","author":"Tripathi","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102961_bib183","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jchemneu.2017.12.006","article-title":"Prevention of chronic immobilization stress-induced enhanced expression of glucocorticoid receptors in the prefrontal cortex by inactivation of basolateral amygdala","volume":"95","author":"Tripathi","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.arr.2025.102961_bib184","doi-asserted-by":"crossref","unstructured":"Tyagi, K., Sarup, P. and Malik, J., 2025. Alzheimer\u2019s Disease: Pathophysiological and Therapeutical Insights. In Diet and Alzheimer's Disease: Let Food be Our Medicine (pp. 1-35). Singapore: Springer Nature Singapore.","DOI":"10.1007\/978-981-95-2736-6_1"},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1743-0003-11-79","article-title":"Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: A randomized double blind controlled pilot trial","volume":"11","author":"Tyler","year":"2014","journal-title":"J. Neuroeng. Rehabil."},{"issue":"7","key":"10.1016\/j.arr.2025.102961_bib186","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1474-4422(11)70121-1","article-title":"Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases","volume":"10","author":"Uccelli","year":"2011","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.arr.2025.102961_bib187","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/biom12050603","article-title":"Advances in Visualizing Microglial Cells in Human Central Nervous System Tissue","volume":"12","author":"Uff","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib188","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41467-024-46068-3","article-title":"Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation","volume":"15","author":"Van Den Bosch","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.arr.2025.102961_bib189","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00429-017-1383-5","article-title":"Human astrocytes: Structure and functions in the healthy brain","volume":"222","author":"Vasile","year":"2017","journal-title":"Brain Struct. Funct."},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib190","doi-asserted-by":"crossref","DOI":"10.23736\/S1973-9087.22.07217-3","article-title":"Management of bladder dysfunction in multiple sclerosis: A systematic review and meta-analysis of studies regarding bladder rehabilitation","volume":"58","author":"Vecchio","year":"2022","journal-title":"Eur. J. Phys. Rehabil. Med."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib191","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/neuroglia1010013","article-title":"The History of the Decline and Fall of the Glial Numbers Legend","volume":"1","author":"Verkhratsky","year":"2018","journal-title":"Neuroglia"},{"key":"10.1016\/j.arr.2025.102961_bib192","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.997786","article-title":"Microglia morphophysiological diversity and its implications for the CNS","volume":"13","author":"Vidal-Itriago","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib193","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13195-015-0139-9","article-title":"Immune phenotypes of microglia in human neurodegenerative disease: Challenges to detecting microglial polarization in human brains","volume":"7","author":"Walker","year":"2015","journal-title":"Alzheimer\u2019S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102961_bib194","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.773590","article-title":"Microglia Heterogeneity in Alzheimer\u2019s Disease: Insights From Single-Cell Technologies","volume":"13","author":"Wang","year":"2021","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.arr.2025.102961_bib195","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.773590","article-title":"Microglia Heterogeneity in Alzheimer\u2019s Disease: Insights From Single-Cell Technologies","volume":"13","author":"Wang","year":"2021","journal-title":"Front. Synaptic Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib196","first-page":"1032","article-title":"Assessment and Treatment Strategies for a Multiple Sclerosis Relapse","volume":"5","author":"Wang","year":"2018","journal-title":"J. Immunol. Clin. Res."},{"issue":"8","key":"10.1016\/j.arr.2025.102961_bib197","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3174\/ajnr.A0594","article-title":"Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy","volume":"28","author":"Wattjes","year":"2007","journal-title":"Ajnr. Am. J. Neuroradiol."},{"key":"10.1016\/j.arr.2025.102961_bib198","unstructured":"Wei, D.C., & Morrison, E.H. (2024). Histology, Astrocytes. In StatPearls. StatPearls Publishing. \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545142\/\u3009."},{"key":"10.1016\/j.arr.2025.102961_bib199","unstructured":"Weill Medical College of Cornell University. (2022). Measuring Active Microglia in Progressive Multiple Sclerosis (Clinical Trial Registration No. NCT02207075). clinicaltrials.gov. \u3008https:\/\/clinicaltrials.gov\/study\/NCT02207075\u3009."},{"issue":"13","key":"10.1016\/j.arr.2025.102961_bib200","doi-asserted-by":"crossref","DOI":"10.3390\/cells11132091","article-title":"Microglia Phenotypes in Aging and Neurodegenerative Diseases","volume":"11","author":"Wendimu","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.arr.2025.102961_bib201","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/14737175.2019.1614443","article-title":"Glial cells as therapeutic targets in progressive multiple sclerosis","volume":"19","author":"Wilbanks","year":"2019","journal-title":"Expert Rev. Neurother."},{"issue":"7","key":"10.1016\/j.arr.2025.102961_bib202","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11940-019-0574-1","article-title":"Approaches to Remyelination Therapies in Multiple Sclerosis","volume":"21","author":"Wooliscroft","year":"2019","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.arr.2025.102961_bib203","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.896852","article-title":"Functional and phenotypic diversity of microglia: implication for microglia-based therapies for Alzheimer\u2019s disease","volume":"14","author":"Xu","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102961_bib204","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.896852","article-title":"Functional and phenotypic diversity of microglia: implication for microglia-based therapies for Alzheimer\u2019s disease","volume":"14","author":"Xu","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"S1","key":"10.1016\/j.arr.2025.102961_bib205","doi-asserted-by":"crossref","DOI":"10.21037\/tau.2016.s233","article-title":"AB233. PDE5-Is for erectile dysfunction in patients with multiple sclerosis","volume":"5","author":"Yang","year":"2016","journal-title":"Transl. Androl. Urol."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib206","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41598-018-19303-3","article-title":"Relapsing-Remitting Multiple Sclerosis diagnosis from cerebrospinal fluids via Fourier transform infrared spectroscopy coupled with multivariate analysis","volume":"8","author":"Yonar","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.arr.2025.102961_bib207","first-page":"266","article-title":"Amyloid\u2010\u03b2 in Alzheimer\u2019s disease: Structure, toxicity, distribution, treatment, and prospects","volume":"10","author":"Yu","year":"2024","journal-title":"ibrain"},{"key":"10.1016\/j.arr.2025.102961_bib208","first-page":"1","article-title":"The appropriate marker for astrocytes: comparing the distribution and expression of three astrocytic markers in different mouse cerebral regions","volume":"2019","author":"Zhang","year":"2019","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.arr.2025.102961_bib209","article-title":"Astrocyte metabolism and signaling pathways in the CNS","volume":"17","author":"Zhang","year":"2023","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.arr.2025.102961_bib210","article-title":"Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis","volume":"2018","author":"Zhang","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.arr.2025.102961_bib211","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13023-021-01694-8","article-title":"Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials","volume":"16","author":"Zhang","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.arr.2025.102961_bib212","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.3390\/ijms24076373","article-title":"Mechanisms of demyelination and remyelination strategies for multiple sclerosis","volume":"24","author":"Zhao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102961_bib213","first-page":"105","article-title":"Glial regulation of energy metabolism","volume":"1090","author":"Zhou","year":"2018"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725003071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725003071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:21:26Z","timestamp":1773865286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725003071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":213,"alternative-id":["S1568163725003071"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.102961","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding glial cells: Implications for multiple sclerosis pathogenesis and therapeutics","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.102961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102961"}}